...
首页> 外文期刊>Journal of investigational allergology & clinical immunology: official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunologie >Incidence and Risk Factors of Immediate Hypersensitivity Reactions Associated With Low-Osmolar Iodinated Contrast Media: A Longitudinal Study Based on a Real-Time Monitoring System
【24h】

Incidence and Risk Factors of Immediate Hypersensitivity Reactions Associated With Low-Osmolar Iodinated Contrast Media: A Longitudinal Study Based on a Real-Time Monitoring System

机译:低渗碘化造影剂引起的立即超敏反应的发生率和危险因素:基于实时监测系统的纵向研究

获取原文
           

摘要

Objectives: We investigated the incidence of immediate hypersensitivity reaction (HSR) caused by different types of low-osmolar contrast media (LOCM) and cumulative exposure to LOCM.Methods: This cohort study included all consecutive patients who underwent LOCM-enhanced computed tomography from 2012 through 2014. We assessed 5 LOCM (iobitridol, iohexol, iomeprol, iopamidol, and iopromide). All patients were monitored for adverse events, and new symptoms and signs were recorded in real time using the Contrast Safety Monitoring and Management System (CoSM 2 oS).Results: The overall incidence of immediate HSR to LOCM was 0.97% (2004 events resulting from 205 726 exposures). Incidence differed significantly depending on whether the patient had a previous history of HSR to LOCM (0.80% in patients with no history and 16.99% in patients with a positive history of HSR to LOCM, P =.001). The incidence of HSR to individual LOCM ranged from 0.72% (iohexol) to 1.34% (iomeprol), although there were no significant differences across the 5 LOCM. A longitudinal analysis demonstrated that the incidence of HSR increased gradually with more frequent previous exposure to LOCM (HR=2.006 [95%CI, 1.517-2.653], P <.001). However, this cumulative increase in risk was observed in patients who had experienced HSR to LOCM, but not in those who had not.Conclusion: The incidence of HSR did not differ significantly across the 5 LOCM assessed in the study. Repeated exposure to LOCM did not increase the risk of HSR among patients who had never experienced HSR to LOCM.
机译:目的:我们调查了由不同类型的低渗造影剂(LOCM)和累积暴露于LOCM引起的立即超敏反应(HSR)的发生率。方法:该队列研究包括自2012年以来接受LOCM增强计算机断层扫描的所有连续患者到2014年。我们评估了5种LOCM(碘比妥醇,碘海醇,碘美普尔,碘帕醇和碘普罗米特)。所有患者均接受了不良事件监测,并使用对比安全监测和管理系统(CoSM 2 oS)实时记录了新的症状和体征。结果:立即发生的HSR到LOCM的总发生率为0.97%(2004年的事件是由205726次曝光)。根据患者是否有HSR到LOCM的既往病史,发病率差异显着(无病史的患者为0.80%,对LOCM的病史为阳性的患者为16.99%,P = .001)。尽管5个LOCM之间没有显着差异,但单个LOCM的HSR发生率在0.72%(碘海醇)至1.34%(碘美普尔)之间。一项纵向分析表明,随着以前更频繁地接触LOCM,HSR的发生率逐渐增加(HR = 2.006 [95%CI,1.517-2.653],P <.001)。但是,在经历过LOCM的HSR的患者中观察到了这种累积的风险增加,而没有经历过LOCM的患者则没有。结论:在本研究评估的5个LOCM中,HSR的发生率没有显着差异。从未接触过LOCM的患者中,反复接触LOCM不会增加HSR的风险。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号